Molecular Templates Inc (MTEM)
1.305
-0.10
(-6.79%)
USD |
NASDAQ |
Jun 14, 16:00
1.27
-0.04
(-2.68%)
After-Hours: 20:00
Molecular Templates Max Drawdown (5Y): 99.58% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 99.58% |
April 30, 2024 | 99.46% |
March 31, 2024 | 99.36% |
February 29, 2024 | 98.75% |
January 31, 2024 | 98.74% |
December 31, 2023 | 98.66% |
November 30, 2023 | 98.24% |
October 31, 2023 | 98.22% |
September 30, 2023 | 98.22% |
August 31, 2023 | 98.22% |
July 31, 2023 | 98.22% |
June 30, 2023 | 98.22% |
May 31, 2023 | 98.22% |
April 30, 2023 | 98.22% |
March 31, 2023 | 98.22% |
February 28, 2023 | 98.20% |
January 31, 2023 | 98.20% |
December 31, 2022 | 98.20% |
November 30, 2022 | 97.18% |
October 31, 2022 | 96.84% |
September 30, 2022 | 96.42% |
August 31, 2022 | 96.03% |
July 31, 2022 | 95.56% |
June 30, 2022 | 95.56% |
May 31, 2022 | 94.68% |
Date | Value |
---|---|
April 30, 2022 | 95.50% |
March 31, 2022 | 95.86% |
February 28, 2022 | 95.86% |
January 31, 2022 | 95.86% |
December 31, 2021 | 95.86% |
November 30, 2021 | 95.86% |
October 31, 2021 | 95.86% |
September 30, 2021 | 95.86% |
August 31, 2021 | 95.97% |
July 31, 2021 | 95.97% |
June 30, 2021 | 95.97% |
May 31, 2021 | 95.97% |
April 30, 2021 | 95.97% |
March 31, 2021 | 96.03% |
February 28, 2021 | 96.43% |
January 31, 2021 | 96.43% |
December 31, 2020 | 96.61% |
November 30, 2020 | 97.48% |
October 31, 2020 | 97.48% |
September 30, 2020 | 97.48% |
August 31, 2020 | 97.48% |
July 31, 2020 | 97.48% |
June 30, 2020 | 97.48% |
May 31, 2020 | 97.48% |
April 30, 2020 | 97.48% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.68%
Minimum
May 2022
99.58%
Maximum
May 2024
97.20%
Average
97.48%
Median
Jun 2019
Max Drawdown (5Y) Benchmarks
AIM ImmunoTech Inc | 99.76% |
Perspective Therapeutics Inc | 91.70% |
Protalix BioTherapeutics Inc | 94.35% |
Electromed Inc | 55.84% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -78.70 |
Beta (5Y) | 1.203 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 71.37% |
Historical Sharpe Ratio (5Y) | -0.8717 |
Historical Sortino (5Y) | -1.468 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.34% |